Levine M M
Ciba Found Symp. 1981;80:142-60. doi: 10.1002/9780470720639.ch10.
Enterotoxigenic Escherichia coli (ETEC), an important cause of diarrhoea in humans and animal, require accessory virulence properties in addition to enterotoxin to manifest virulence. Several classes of pili (hair-like protein surface organelles) promote adhesion of ETEC to small intestinal mucosa. Antibody directed against adhesion pili interferes with colonization of the small intestine and prevents disease. This paper reviews studies with purified K88, K99 and 987 type pili used as parenteral vaccines in pregnant pigs and cattle. Infant animals suckled on immunized mothers were significantly protected against fatal disease. Colonization factor antigen (CFA) I and II pili, and type 1 somatic pili, promote adhesion of human ETEC pathogens to epithelial cells in vitro and are generally recognized as accessory virulence factors. CFA/I and II were found in only 25% of 36 human ETEC infections; positive strains were usually LT+/ST+ (LT: heat-labile; ST: heat-stable). Strains lacking CFA/I and II are virulent; other factors must be responsible for adhesion in such strains. While none of 14 LT+/ST- strains elaborated CFA/I or II, 10 (71%) possessed type 1 somatic pili. An initial ETEC diarrhoeal infection in volunteers stimulated protective immunity against diarrhoea on re-challenge with the same strain. Despite clinical protection healthy "veterans" excreted the ETEC strain to the same degree as ill controls. Thus the mechanisms of immunity was not bactericidal. Disease-induced LT antitoxic immunity failed to protect volunteers against challenge with a heterologous (LT+/ST-) strain. One explanation of these observations is that the mechanism of protection was anti-adhesive with antibody directed against adhesive factors on the bacterial surface preventing attachment of bacteria to receptors on small intestinal mucosal cells. Immunoprophylaxis against ETEC in humans with purified pili vaccines appears feasible.
产肠毒素大肠杆菌(ETEC)是人和动物腹泻的重要病因,除肠毒素外还需要其他辅助毒力特性才能表现出毒力。几类菌毛(毛发样蛋白质表面细胞器)可促进ETEC黏附于小肠黏膜。针对黏附菌毛的抗体可干扰小肠定植并预防疾病。本文综述了将纯化的K88、K99和987型菌毛用作怀孕猪和牛的肠外疫苗的研究。吃了免疫母猪乳汁的幼畜受到显著保护,免于致命疾病。定居因子抗原(CFA)I和II菌毛以及1型菌体菌毛可促进人类ETEC病原体在体外黏附于上皮细胞,通常被认为是辅助毒力因子。在36例人类ETEC感染中,仅25%发现了CFA/I和II;阳性菌株通常为LT+/ST+(LT:不耐热;ST:耐热)。缺乏CFA/I和II的菌株具有毒力;此类菌株中必定有其他因子负责黏附。虽然14株LT+/ST-菌株均未产生CFA/I或II,但其中10株(71%)具有1型菌体菌毛。志愿者初次感染ETEC腹泻后,再次接触同一菌株时可激发对腹泻的保护性免疫。尽管有临床保护作用,但健康的“康复者”排出ETEC菌株的程度与患病对照相同。因此,免疫机制不是杀菌性的。疾病诱导的LT抗毒素免疫未能保护志愿者免受异源(LT+/ST-)菌株的攻击。对这些观察结果的一种解释是,保护机制是抗黏附性的,即针对细菌表面黏附因子的抗体可阻止细菌附着于小肠黏膜细胞上的受体。用纯化菌毛疫苗对人类进行ETEC免疫预防似乎是可行的。